Immix Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $16,141,113.
Profit Margin
| 2019 | 0 | -972.81K | |
|---|---|---|---|
| 2020 | 0 | -1.14M | |
| 2021 | 0 | -24.38M | |
| 2022 | -89.51M | -8.22M | 9.19% |
| 2023 | 0 | -15.42M |
IMMX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | -89.51M | 0 | 0 | 0 |
Cost of revenue | 5.46K | 2.13K | 2.46K | 2.32K | 1.08K |
Gross profit | -5.46K | -89.51M | -2.46K | -2.32K | -1.08K |
Operating exp. | |||||
Research and development | 8.73M | 4.19M | 126.52K | 248.14K | 583.16K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 16.14M | 8.21M | 1.35M | 453.85K | 842.49K |
Operating income | -16.14M | -8.21M | -1.35M | -453.85K | -842.49K |
Other income (expenses), net | 572.00K | -497 | -23.02M | -676.46K | -109.76K |
Income before tax | -15.56M | -8.21M | -24.37M | -1.13M | -952.25K |
Income tax expense | 26.41K | 10.26K | 6.01K | 17.54K | 20.55K |
Net income | -15.42M | -8.22M | -24.38M | -1.14M | -972.81K |
Earnings per share | |||||
Basic EPS | -0.89 | -0.62 | -1.84 | -0.15 | -0.13 |
Diluted EPS | -0.89 | -0.62 | -1.84 | -0.15 | -0.13 |
| Data source | Data source | Data source |